[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 7336 Introduced in House (IH)]

<DOC>






119th CONGRESS
  2d Session
                                H. R. 7336

To amend title XVIII of the Social Security Act to provide coverage of 
    ALS-related services under the Medicare program for individuals 
 diagnosed with amyotrophic lateral sclerosis, and for other purposes.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                            February 3, 2026

    Ms. Schakowsky (for herself, Mr. Fitzpatrick, Mr. Crow, and Mr. 
   Quigley) introduced the following bill; which was referred to the 
 Committee on Energy and Commerce, and in addition to the Committee on 
   Ways and Means, for a period to be subsequently determined by the 
  Speaker, in each case for consideration of such provisions as fall 
           within the jurisdiction of the committee concerned

_______________________________________________________________________

                                 A BILL


 
To amend title XVIII of the Social Security Act to provide coverage of 
    ALS-related services under the Medicare program for individuals 
 diagnosed with amyotrophic lateral sclerosis, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``ALS Better Care Act''.

SEC. 2. FINDINGS.

    Congress makes the following findings:
            (1) Amyotrophic lateral sclerosis (in this section, 
        referred to as ``ALS'') is a progressive and debilitating 
        neurodegenerative disease.
            (2) Key services that include (but are not limited to) 
        providing specialized physician or nurse practitioner support, 
        occupational therapy support, speech pathology support, 
        physical therapy, dietary support, respiratory support, 
        registered nurse support, and coordination of the furnishing of 
        durable medical equipment are crucial for managing the complex 
        medical needs of ALS patients.
            (3) Studies have shown ALS clinics that provide these key 
        services to ALS patients extend these patients' lifespans and 
        improve the quality of their lives.
            (4) These key services are furnished by a range of 
        healthcare professionals.
            (5) Facilities providing care to ALS patients currently 
        face inadequate Medicare reimbursement for the key services 
        they offer to these patients.
            (6) Insufficient reimbursement creates significant 
        challenges for facilities specializing in ALS care, resulting 
        in extended wait times for patients in need of crucial services 
        and hampering the ability of these facilities to innovate and 
        improve the quality of care provided to ALS patients.
            (7) Improved reimbursement rates would encourage facilities 
        to invest in research, innovation, and technology, leading to 
        enhanced treatment options for ALS and improved patient 
        outcomes.
            (8) Remote medical management options for individuals 
        suffering from ALS must be a crucial part of access to care for 
        such individuals, especially those living in rural areas or 
        care deserts.
            (9) Telehealth is an essential management option referred 
        to in paragraph (8) and can assist in delivering timely and 
        comprehensive care, as ALS patients living in rural areas or 
        care deserts often face challenges in accessing specialized ALS 
        care and could otherwise be required to travel long distances--
        often with caregivers or family members.
            (10) Telehealth is especially important in maintaining 
        access to care for ALS patients as the disease progresses and 
        ALS patients have more limited mobility, which may make it 
        challenging to attend in-person appointments regularly.
            (11) Low funding and difficulty in staffing for ALS 
        clinical trials delay the development and availability of 
        potential treatments and therapies for individuals living with 
        the disease.
            (12) Inadequate funding for ALS clinical trials also 
        impedes the ability to attract and retain qualified 
        researchers, clinicians, and support staff, limiting the 
        overall progress and success of these trials.

SEC. 3. PROVIDING FOR COVERAGE OF ALS-RELATED SERVICES UNDER THE 
              MEDICARE PROGRAM FOR INDIVIDUALS DIAGNOSED WITH 
              AMYOTROPHIC LATERAL SCLEROSIS.

    (a) In General.--Section 1861 of the Social Security Act (42 U.S.C. 
1395x) is amended--
            (1) in subsection (s)(2)--
                    (A) by adding ``and'' at the end of subparagraph 
                (JJ); and
                    (B) by adding at the end the following new 
                subparagraph:
                    ``(KK) ALS-related services (as defined in 
                subsection (nnn)) furnished on or after January 1, 
                2027;''; and
            (2) by adding at the end the following new subsection:
    ``(nnn) ALS-Related Services.--
            ``(1) Als-related services.--The term `ALS-related 
        services' means the following items and services that are 
        furnished to a covered ALS individual in an outpatient setting 
        by a qualified provider (as defined in section 1834(aa)(6)) (or 
        by another provider of services under an arrangement made by a 
        qualified provider) for the care and treatment of such an 
        individual with respect to the progression of amyotrophic 
        lateral sclerosis:
                    ``(A) Specialized physician or nurse practitioner 
                support.
                    ``(B) Occupational therapy support.
                    ``(C) Speech pathology support.
                    ``(D) Physical therapy.
                    ``(E) Dietary support.
                    ``(F) Respiratory support.
                    ``(G) Registered nurse support.
                    ``(H) Coordination of the furnishing of durable 
                medical equipment necessary for the management of the 
                complex medical needs of a covered ALS individual.
            ``(2) Covered als individual.--The term `covered ALS 
        individual' means an individual who is medically determined to 
        have amyotrophic lateral sclerosis (as described in section 
        226(h)).''.
    (b) Payment for ALS-Related Services.--Section 1834 of the Social 
Security Act (42 U.S.C. 1395m) is amended by adding at the end the 
following new subsections:
    ``(aa) Payment for ALS-Related Services.--
            ``(1) In general.--The Secretary shall implement a payment 
        system under which a single payment determined in accordance 
        with the succeeding paragraphs is made to a qualified provider 
        (as defined in paragraph (6)) for ALS-related services (as 
        defined in paragraph (1) of section 1861(nnn)) furnished to a 
        covered ALS individual (as defined in paragraph (2) of such 
        section) during a visit, in addition to any other payment that 
        may be made for such services under this title.
            ``(2) Base payment amount.--
                    ``(A) In general.--The amount of the single payment 
                described in paragraph (1) for ALS-related services 
                furnished during a year is equal to--
                            ``(i) for 2027, $800;
                            ``(ii) for 2028, $800 (or, if greater, the 
                        payment amount recommended by the Comptroller 
                        General of the United States in the report 
                        described in subparagraph (C)); and
                            ``(iii) for 2029 and each subsequent year--
                                    ``(I) the amount for the preceding 
                                year, increased by the ALS services 
                                market basket percentage increase (as 
                                defined in clause (i) of subparagraph 
                                (B)) for such year; or
                                    ``(II) in the case such year is an 
                                applicable year (as defined in clause 
                                (ii) of such subparagraph), the payment 
                                amount recommended by the Comptroller 
                                General in the most recent report 
                                submitted under subparagraph (C), if 
                                greater than the amount that would be 
                                determined for such year under 
                                subclause (I).
                    ``(B) Definitions.--In this paragraph:
                            ``(i) ALS services market basket percentage 
                        increase.--The term `ALS services market basket 
                        percentage increase' means, for a year, the 
                        Secretary's estimate of the percentage increase 
                        in costs of an appropriate mix, as determined 
                        by the Secretary, of items and services that 
                        are ALS-related services over the preceding 
                        year.
                            ``(ii) Applicable year.--The term 
                        `applicable year' means 2030 and every third 
                        year thereafter.
                    ``(C) Report by the comptroller general.--
                            ``(i) In general.--Not later than January 
                        1, 2027, and not later than January 1 of every 
                        third year thereafter, the Comptroller General 
                        of the United States shall, in consultation 
                        with qualified providers eligible for payment 
                        under this subsection, submit to the Secretary 
                        a report that recommends a single payment 
                        amount for ALS-related services that takes into 
                        account the average amount of payment for each 
                        item or service included in ALS-related 
                        services that the Comptroller General estimates 
                        would have been payable--
                                    ``(I) under this title for such a 
                                service based on per patient 
                                utilization data from whichever single 
                                year during the covered period (as 
                                defined in clause (ii)) with respect to 
                                such report has the highest per patient 
                                utilization of ALS-related services, 
                                even if such service is not payable for 
                                a particular covered ALS individual 
                                because of the application of section 
                                1862(a)(1)(A) with respect to an item 
                                or service provided to such individual;
                                    ``(II) in the case an estimate is 
                                unable to be determined pursuant to 
                                subclause (I), by health insurance 
                                issuers and group health plans (as such 
                                terms are defined in section 2791 of 
                                the Public Health Service Act) and MA 
                                plans under part C for such a service, 
                                based on such data from whichever 
                                single year during the covered period 
                                with respect to such report has the 
                                highest per patient utilization of ALS-
                                related services; and
                                    ``(III) in the case an estimate is 
                                unable to be determined pursuant to 
                                subclause (II), based on the 
                                recommendation of the Specialty Society 
                                Relative Value Scale Update Committee 
                                of the American Medical Association or 
                                the estimate of the Comptroller General 
                                for such a service.
                            ``(ii) Definition of covered period.--In 
                        this subparagraph, the term `covered period' 
                        means--
                                    ``(I) with respect to the first 
                                report submitted under this 
                                subparagraph, 2022 through 2024;
                                    ``(II) with respect to the second 
                                such report, 2026 through 2028; and
                                    ``(III) with respect to the third 
                                report and each subsequent report, the 
                                period that begins 3 years after the 
                                covered period for the preceding 
                                report.
            ``(3) Payment adjustments.--The payment system under this 
        subsection shall include a payment adjustment--
                    ``(A) for each qualified provider that is 
                participating in at least one clinical trial identified 
                on the clinicaltrials.gov database (or any successor 
                database) of the National Institutes of Health to 
                account for the increased cost borne by such a 
                qualified provider during such a clinical trial; and
                    ``(B) for a medical service or technology which is 
                furnished as a part of ALS-related services for which, 
                as determined by the Secretary--
                            ``(i) payment under this subsection for 
                        such service or technology was not being made 
                        in the preceding year; and
                            ``(ii) the cost of such service or 
                        technology is not insignificant in relation to 
                        the payment amount (as determined under this 
                        subsection) payable for ALS-related services.
            ``(4) Mechanism for payments.--For purposes of making 
        payments for ALS-related services, the Secretary shall 
        establish a mechanism under the payment system under this 
        subsection which makes payment when a qualified provider 
        submits a claim for payment which includes, with respect to a 
        covered ALS individual, an alphanumeric code issued under the 
        International Classification of Diseases, 10th Revision, 
        Clinical Modification (`ICD-10-CM') and its subsequent 
        revisions that is for the treatment of a diagnosis of 
        amyotrophic lateral sclerosis.
            ``(5) No cost sharing.--Payment under this subsection shall 
        be made only on an assignment-related basis without any cost 
        sharing.
            ``(6) Qualified provider.--In this section, the term 
        `qualified provider' means a provider of services that--
                    ``(A) is capable of furnishing ALS-related 
                services; and
                    ``(B) meets requirements as the Secretary 
                prescribes by regulation to implement subparagraph (A), 
                in consultation with--
                            ``(i) covered ALS individuals and their 
                        representatives;
                            ``(ii) physicians who provide ALS-related 
                        services and their representatives; and
                            ``(iii) professional and non-profit 
                        organizations with expertise in amyotrophic 
                        lateral sclerosis.
            ``(7) Implementation.--
                    ``(A) In general.--Except as provided under 
                subparagraph (B), the Secretary may implement the 
                provisions of this subsection by program instruction or 
                otherwise.
                    ``(B) Rulemaking.--The Secretary shall implement 
                paragraph (6), through notice and comment 
                rulemaking.''.
    (c) Conforming Amendments.--
            (1) Section 1833(t).--Section 1833(t) of the Social 
        Security Act (42 U.S.C. 1395(t)) is amended by adding at the 
        end the following new paragraph:
            ``(23) Ensuring supplemental payments for als-related 
        services.--Any covered OPD service furnished to a covered ALS 
        individual (as defined in section 1861(nnn)(2)) that is 
        otherwise payable to a qualified provider (as defined in 
        section 1834(aa)(6)) pursuant to paragraph (4) shall be payable 
        under such paragraph notwithstanding any payment made under 
        section 1834(aa).''.
            (2) Definition of arrangements.--Section 1861(w)(1) of the 
        Social Security Act (42 U.S.C. 1395x(w)(1)) is amended by 
        inserting ``qualified provider (as defined in section 
        1834(aa)(6)) with respect to ALS-related services (as defined 
        in subsection (nnn)),'' before ``or hospice program''.

SEC. 4. REPORT ON CHALLENGES WITH RESPECT TO THE ADMINISTRATION AND 
              STAFFING OF AMYOTROPHIC LATERAL SCLEROSIS CLINICAL 
              TRIALS.

    Not later than 90 days after the date of the enactment of this Act, 
the Secretary of Health and Human Services, acting through the Director 
of the National Institute of Neurological Disorders and Stroke of the 
National Institutes of Health, shall submit to Congress and publish on 
the internet website of the agency a report that identifies--
            (1) any challenges with respect to the administration and 
        staffing of clinical trials for the prevention, diagnosis, 
        mitigation, treatment, or cure of amyotrophic lateral 
        sclerosis;
            (2) actions that the Director of the National Institute of 
        Neurological Disorders and Stroke can take to address such 
        challenges; and
            (3) any legislative recommendations (including requests for 
        appropriations) to further improve the administration of such 
        clinical trials.
                                 <all>